MIAMI, FL--(Marketwired - Apr 13, 2015) - Novus Acquisition & Development Corp. (OTC PINK: NDEV), through its wholly owned Novus Medical Group subsidiary, provides a healthcare program called "Novus MedPlan" that offers a cost saving medical plan for patients within the wellness industry, including the medical marijuana (MMJ) arena. Today Novus announces that its Novus MedPlan, through its Provider Network, will be offering the nationally renowned "Charlotte's Web" through its interactive web portal. The agreement with this Provider is an exclusive basis for 30% off the retail price and Novus MedPlan will not offer this product through any other provider.
Charlotte's Web is a form of medical cannabis processed into a marijuana extract that is high in cannabidiol ("CBD") content. Due to its extremely low amount of tetrahydrocannabinol ("THC"), it does not induce the psychoactive "high" associated with most marijuana strains that contain elevated levels of THC. Charlotte's Web was named after Charlotte Figi, who was diagnosed with Dravet Syndrome, also known as myoclonic epilepsy, when she was two years old. Her parents and physicians say she experienced a reduction in epileptic seizures after being dosed with a unique, low THC and high CBD product that became known as Charlotte's Web. As many as 2.5 million Americans are afflicted with epilepsy that Charlotte's Web is designed to treat, many are children, and some parents feel they have run out of pharmaceutical options. With Novus MedPlan's online ordering, families will have easier access to Charlotte's Web across several states where approved programs exist.
Frank Labrozzi CEO stated, "Novus MedPlan's convenient online ordering platform provides easy access to medications and therapies, while providing a substantial discount to help make them more affordable. With many alternative medications and therapies not covered under conventional insurance, we aim to fill the gap and bring much-needed medications and therapies to the masses in states where legal programs exist."
To enroll or take a tour of the Novus MedPlan, visit novusmedicalgroup.com and experience the ground-breaking ways that patients get relief from the high costs of treatments for only $19.95 per month.
Novus Acquisition & Development Corp. ("Novus") provides health insurance and related insurance solutions within the wellness and Cannabis (Medical Marijuana) industries in states where legal programs exist. The Company also plans to offer physicians' education programs, pharmaceutical R&D, compliance, and business development services within the industries.
NDEV will work as outside developers and will not cultivate, handle, transport, grow, extract, dispense, put up for sale, put on the market, vend, deliver, supply, circulate, or trade cannabis or any substances that violate the United States law or the Controlled Substances Act, nor does it intend to do so in the future; NDEV will continue to follow state and federal laws. The products and statements made about specific products have not been evaluated by the United States Food and Drug Administration (FDA) and are not intended to diagnose, treat, cure or prevent disease. All information provided on these press releases or any information contained on or in any product label or packaging is for informational purposes only and is not intended as a substitute for advice from your physician or other health care professional. Once a push notification is competed the transaction is solely between the state licensed dispensary and the registered patient.
The state laws are in conflict with the federal Controlled Substances Act. The current administration has effectively stated that it is not an efficient use of resources to direct federal law enforcement agencies to prosecute those lawfully abiding by state designated laws allowing the use and distribution of medical marijuana. However, there is no guarantee that the current administration, nor any future administration, will not change this policy and decide to enforce the federal laws strongly. Any such change in the federal government's enforcement of current federal laws could cause significant financial changes to the Company. While we do not intend to harvest, distribute or sell cannabis or cannabis related products, we may be harmed by a change in enforcement by federal or state governments.
About Charlotte's Web
*Restrictions on Charlotte's Web™ cannot be shipped to NY, FL or NV. Orders made with a shipping address in those states will be emailed and given the option to exchanged their order for something else or have their order refunded. Sorry for the inconvenience. Charlotte's Web™ (CW) Hemp Extract in MCT infuses genuine Charlotte's Web™ Hemp Extract into MCT oil -- fractionated coconut oil -- with a pleasing organic chocolate mint flavoring. As a whole plant extract, CW Hemp Extract in MCT contains not only 200 mg or 500 mg of CBD per bottle, but also incorporates other naturally occurring elements, terpenes and phytochemicals found in our proprietary hemp strains. CW™ Botanicals is a family owned Colorado Company that provides CBD-rich hemp products for a variety of general wellness needs. The founders have over 25 years of combined experience in the hemp industry. All Charlotte's Web™ products are made from world-renowned hemp genetics, grown internationally as well as in Colorado. CW Botanicals controls the entire manufacturing process -- from seed to packaged product, to ensure the highest standards of purity and quality.
This release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, includes codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Note that Charlotte's Web While high profile and anecdotal reports have sparked interest in treatment with cannabinoids, there is insufficient medical evidence to draw conclusions about their safety or efficacy.